Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-10-18
DOI
10.1038/srep35314
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peripheral Blood T Cell Dynamics Predict Relapse in Multiple Sclerosis Patients on Fingolimod
- (2015) Zi-Ye Song et al. PLoS One
- Immunology of Relapse and Remission in Multiple Sclerosis
- (2014) Lawrence Steinman Annual Review of Immunology
- An update on new adoptive immunotherapy strategies for solid tumors with cytokine-induced killer cells
- (2014) Clara E Jäkel et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Increased numbers and functional activity of CD56+T cells in healthy cytomegalovirus positive subjects
- (2014) Mazen Almehmadi et al. IMMUNOLOGY
- FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination
- (2014) Caroline A Blanc et al. Journal of Neuroinflammation
- Tumefactive demyelination and a malignant course in an MS patient during and following fingolimod therapy
- (2014) M.A. Hellmann et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Cytokine Induced Killer (CIK) cells for the treatment of haematological neoplasms
- (2013) M. Introna et al. IMMUNOLOGY LETTERS
- Cytotoxic NKG2C+ CD4 T Cells Target Oligodendrocytes in Multiple Sclerosis
- (2013) F. Zaguia et al. JOURNAL OF IMMUNOLOGY
- Relapse of multiple sclerosis in a patient retaining CCR7-expressing T cells in CSF under fingolimod therapy
- (2013) Akiko Yokoseki et al. Multiple Sclerosis Journal
- Tumefactive MS lesions under fingolimod: A case report and literature review
- (2013) G. Pilz et al. NEUROLOGY
- T-cell response against varicella-zoster virus in fingolimod-treated MS patients
- (2013) M. E. Ricklin et al. NEUROLOGY
- T-cell trafficking in the central nervous system
- (2012) Federica Sallusto et al. IMMUNOLOGICAL REVIEWS
- Increased numbers but functional defects of CD56+CD3+ cells in lung cancer
- (2012) S. Y. Al Omar et al. INTERNATIONAL IMMUNOLOGY
- Tumefactive multiple sclerosis lesions under fingolimod treatment
- (2012) F. Visser et al. NEUROLOGY
- Pharmacodynamic Effects of Steady-State Fingolimod on Antibody Response in Healthy Volunteers: A 4-Week, Randomized, Placebo-Controlled, Parallel-Group, Multiple-Dose Study
- (2011) Craig Boulton et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Increase in the proportion of granulated CD56+ T cells in patients with malignancy
- (2010) Y. TAKII et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
- (2010) Robert C Axtell et al. NATURE MEDICINE
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
- (2010) Volker Brinkmann et al. NATURE REVIEWS DRUG DISCOVERY
- Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
- (2010) M. Mehling et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-β
- (2009) Luca Durelli et al. ANNALS OF NEUROLOGY
- Cytokine-induced killer cells are terminallydifferentiated activated CD8 cytotoxic T-EMRA lymphocytes
- (2009) Marta Franceschetti et al. EXPERIMENTAL HEMATOLOGY
- Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells
- (2008) Monica Montes et al. CLINICAL IMMUNOLOGY
- CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes
- (2008) Li Ye et al. HEPATOLOGY
- FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
- (2008) M. Mehling et al. NEUROLOGY
- Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
- (2007) John S. Tzartos et al. AMERICAN JOURNAL OF PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started